SODIUM PENTOBARBITAL PENTOBARBITAL - AN OVERVIEW

Contraindicated (one)pentobarbital will reduce the level or effect of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers may end up in lessened serum concentrations and lack of antimalarial efficacypentobarbital will minimize the level or effect of dienogest/estradiol